| Overview |
| bsm-61601r-100ul |
| Emerin Recombinant Antibody |
| WB, IHC-P, IHC-F, IF(IHC-P), IF(ICC) |
| Human, Mouse |
| Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Emerin |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 2010 |
| P50402 |
| Nucleus, Cell membrane |
| EDMD; Emd; Emerin; Emery Dreifuss muscular dystrophy; STA. |
| Emerin may regulate gene expression through binding to other transcriptional regulators. Emerin binds to ŚÂ-catenin and inhibits its nuclear accumulation. Recent studies demonstrate that Emerin is required for HIV-1 infectivity. |
| Application Dilution |
| WB |
1:500-2000 |
| IHC-P |
IHC-P1:100-500 |
| IHC-F |
IHC-F1:100-500 |
| IF(IHC-P) |
IFIHC-P1:100-500 |
| IF(ICC) |
IFICC1:50-200 |